Altacor Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Altacor Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10848
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Altacor Ltd (Altacor) is an ophthalmology company that develops and markets orphan products for chronic eye conditions. The company offers prescription and retail ophthalmology products. Its products include dry eye prescription products; dry eye retail products; products for the treatment of dry eye syndrome; eye masks for patients to get relief from blepharitis; age-related macular degeneration and age related eye disease study products; and capsules for eye care. Altacor also offers laser surgery and filtering microsurgery to overcome glaucoma; retinal diseases, ophthalmic surgery and cataract surgery. It sells its products through a network of distributors across Europe. Altacor is headquartered in Cambridge, the UK.

Altacor Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Altacor Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Altacor Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Altacor Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Altacor Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Altacor Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Altacor Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Private Equity 10
Esperante Acquires Altacor from Beringea 10
Partnerships 11
Altacor Enters Into Co-Promotion Agreement With Norgine For Clinitas Dry Eye Product 11
Acquisition 12
NicOx Completes Acquisition Of 11.8% Stake In Altacor For US$3 Million 12
Altacor Ltd – Key Competitors 14
Altacor Ltd – Key Employees 15
Altacor Ltd – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Altacor Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Altacor Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Altacor Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Altacor Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Altacor Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Altacor Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Esperante Acquires Altacor from Beringea 10
Altacor Enters Into Co-Promotion Agreement With Norgine For Clinitas Dry Eye Product 11
NicOx Completes Acquisition Of 11.8% Stake In Altacor For US$3 Million 12
Altacor Ltd, Key Competitors 14
Altacor Ltd, Key Employees 15

List of Figures
Altacor Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Altacor Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Altacor Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Altacor Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Altacor Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Altacor Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Altacor Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Altacor Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Klox Technologies Inc-製薬・医療分野:企業M&A・提携分析
    Summary Klox Technologies Inc (Klox Technologies) is a specialty pharmaceutical company, which focuses on the development and commercialization of a proprietary BioPhotonic technology platform. Its pipeline portfolio includes non-invasive wound care treatment solutions, dermatological treatment solu …
  • Centre for Drug Research and Development:製薬・医療:M&Aディール及び事業提携情報
    Summary Centre for Drug Research and Development (CDRD) is a drug development and commercialization center that provides scientific infrastructure to transform discoveries into innovative therapeutic products and improved health outcomes. The center's drug development platform includes target valida …
  • Sareum Holdings Plc (SAR)-製薬・医療分野:企業M&A・提携分析
    Summary Sareum Holdings Plc (Sareum) is a drug discovery and development company that produces targeted small molecule therapeutics for treating cancer and autoimmune diseases. The drug research programs of the company are based on its proprietary drug discovery technology, SKIL (Sareum Kinase Inhib …
  • UOB Private Banking:企業の戦略・SWOT・財務情報
    UOB Private Banking - Strategy, SWOT and Corporate Finance Report Summary UOB Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Surgical Specialties Corp:企業の戦略・SWOT・財務分析
    Surgical Specialties Corp - Strategy, SWOT and Corporate Finance Report Summary Surgical Specialties Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Royal Dutch Shell plc:企業のM&A・事業提携・投資動向
    Royal Dutch Shell plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Royal Dutch Shell plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Schaffer Corporation Limited (SFC):企業の財務・戦略的SWOT分析
    Schaffer Corporation Limited (SFC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • MS&AD Insurance Group Holdings, Inc.:企業のM&A・事業提携・投資動向
    MS&AD Insurance Group Holdings, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's MS&AD Insurance Group Holdings, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports …
  • Thai Airways International Public Co Ltd
    Thai Airways International Public Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Thai Airways International Public Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Olympus Corp (7733):医療機器:M&Aディール及び事業提携情報
    Summary Olympus Corporation (Olympus) provides precision machinery and instruments. It develops, manufactures and markets equipment and devices for medical, healthcare, imaging, information, and other industrial markets. It offers medical systems such as endotherapy devices, medical endoscopes and t …
  • Inhalation Sciences Sweden AB-医療機器分野:企業M&A・提携分析
    Summary Inhalation Sciences Sweden AB (ISAB) develops and sells innovative laboratory equipment for inhalation research and provides drug development services. The company's product portfolio includes PreciseInhale and LaminarPace systems. It sells tools and services which accelerates the drug disco …
  • Nasstar plc (NASA):企業の財務・戦略的SWOT分析
    Nasstar plc (NASA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Cidara Therapeutics Inc (CDTX):企業の財務・戦略的SWOT分析
    Summary Cidara Therapeutics Inc (Cidara), formerly K2 Therapeutics Inc is a biotechnology company that discovers, develops and commercializes novel anti-infectives including immunotherapies. The company's pipeline products include CD101 for treatment of invasive fungal disease; and CD377 for treatin …
  • Jefferies Group LLC:企業の戦略・SWOT・財務情報
    Jefferies Group LLC - Strategy, SWOT and Corporate Finance Report Summary Jefferies Group LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Tokyo Broadcasting System Holdings, Inc. (9401):企業の財務・戦略的SWOT分析
    Tokyo Broadcasting System Holdings, Inc. (9401) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft:企業の戦略・SWOT・財務情報
    Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft - Strategy, SWOT and Corporate Finance Report Summary Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers th …
  • Pharmascience Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Pharmascience Inc (Pharmascience) is a pharmaceutical company which develops, manufactures and markets generic pharmaceutical products. The company offers generic, prescription, over-the-counter and private label OTC products. It offers drugs in therapeutic areas of anti-inflammatory, cancer …
  • Daiwa House Industry Co Ltd (1925)-エネルギー分野:企業M&A・提携分析
    Summary Daiwa House Industry Co., Ltd. (Daiwa House) is a construction service provider. The company provides diversified real estate solutions such as planning, construction, leasing, management and operation of rental, pre-existing, and new buildings; renovation and real estate agency services. It …
  • Amedica Corp (AMDA):製品パイプライン分析
    Summary Amedica Corp (Amedica) is a biomaterial company. It develops, manufactures and markets medical-grade silicon nitride ceramics for spinal and arthroplasty applications. The company offers interbody fusion devices, pedicle screw systems, facet fixation systems and others. Amedica also offers n …
  • Karo Pharma AB (KARO):製薬・医療:M&Aディール及び事業提携情報
    Summary Karo Pharma AB (Karo Pharma), formerly Karo Bio AB, is a health care company that focuses on research and development of pharmaceutical products in the areas of cancer and autoimmune diseases. Its key research area involves nuclear receptors as target proteins for the development of new phar …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆